Patients with cancer, both active and previously treated, may be at higher risk of severe outcomes from COVID-19 compared to the general population (Dai et al., 2020; Bakouny et al., 2020; Westblade et al., 2020). Oncologists and health care systems have adapted the delivery of cancer care to mitigate the increased risk of morbidity and mortality from COVID-19
among oncology patients (U¨ r€un et al., 2020). However, the ways in which the pandemic has incited changes in multidisciplinary cancer care remain poorly defined with minimal prospective data. In this multicenter, prospective cohort study of 2,365 outpatients receiving cancer care during the pandemic, we detail significant disruptions to routine cancer care and racial disparities in care disruption and COVID-19 outcomes.